Imeik Technology's strong financials and high ROE hint at positive long-term prospects, despite recent hitches. It's 52% income reinvestment and high return rate fuel notable earnings growth. Over next three years, a payout ratio decrease to 37% and ROE rise to 31% are expected.
Imeik Technology DevelopmentLtd's high EPS growth and significant insider ownership indicate possible fundamental improvements. Despite warning signs, it's worth considering for investors interested in fast-growing firms.
Core point 1. In the past three years, China's medical beauty industry has undergone earth-shaking changes, and non-surgical products occupy the mainstream 2. The brand is a marketing tool and a social contract for the legal entity to face society. Last year, it began to issue documents on supervising medical aesthetics, focusing on doctors' qualifications, marketing, and the capabilities of three types of ...
Imeik Technology Developmentに関するコメント
1. In the past three years, China's medical beauty industry has undergone earth-shaking changes, and non-surgical products occupy the mainstream
2. The brand is a marketing tool and a social contract for the legal entity to face society. Last year, it began to issue documents on supervising medical aesthetics, focusing on doctors' qualifications, marketing, and the capabilities of three types of ...
まだコメントはありません